Nasal drug delivery is receiving renewed interest from innovator and generic developers alike. With recent approvals for new modalities, new indications, and improved guidance for in-vitro bioequivalence, investment in this delivery method is set to grow beyond market trends. Ensuring the efficacy, safety, and bioequivalence of these formulations requires precise characterization techniques. From the effect of droplet size on deposition within nasal cavity to the particle size of the active ingredient and its impact on bioavailability.
This webinar will explore the innovative applications of Morphologically-Directed Raman Spectroscopy (MDRS) and Laser Diffraction in the bioequivalence assessment of nasal sprays. Attendees will learn about the principles of both techniques and the recent changes to the regulatory guidance that enable faster routes to market. Join us to discover how MDRS and Laser Diffraction are revolutionizing nasal spray development.
Speakers
- Robert Taylor - Marketing Segment Manager, Malvern Panalytical
More information
Who should attend?
- Scientists and researchers interested in MDRS and Laser diffraction
- Anyone interested in or working on Nasal sprays or OINDP in general
What will you learn?
- Learn about the principles of MDRS and Laser Diffraction and their advantages over traditional methods
- Discover how MDRS combines the morphological analysis of particles with Raman spectroscopy to provide detailed insights into the chemical composition and physical properties of nasal spray formulations
- Understand the impact that new regulatory guidance has on developing nasal spray products